SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

US Facilities Update

24 Mar 2020 07:00

RNS Number : 2917H
Gooch & Housego PLC
24 March 2020
 

For immediate release

24 March 2020

 

 

 

Gooch & Housego PLC

("G&H" or the "Group")

 

US Facilities Update

 

 

 

Gooch & Housego PLC (AIM:GHH), the specialist manufacturer of optical components and systems, announces that as a result of COVID-19 related legal orders issued in the States of Ohio and California the Company's facility in Cleveland, Ohio is now closed for a temporary period; this is in addition to its Fremont, California facility, whose temporary closure was announced on 17 March 2020.

 

During this period staff from Cleveland and Fremont facilities who are able to homework will continue to do so. Work will continue on essential maintenance, inventory management and supplying the small number of customers that are within the exempt sectors.

 

The legal order issued by the State of Ohio is effective through 6 April 2020, the order issued by the State of California is effective until further notice and we are awaiting further details on similar stay at home orders in Maryland and Massachusetts.

 

The Group's Moorpark, California; Baltimore, Maryland and Boston, Massachusetts facilties are not affected by the State of California, Maryland or Massachusetts orders in the same way as they operate substantially within an exempt sector.

 

The Group believes that it is likely that a similar order maybe issued in the coming days in the State of New Hampshire where our other US facility is located. G&H anticipates that the impact of such an order on the Group's operations in Keene, New Hampshire would be limited given a significant proportion of the products and services provided by the facility are expected to be exempt from the scope of the order.

 

It is difficult to provide financial guidance at the current time. Nevertheless the effect of these orders will be to shift the balance of revenue generated by the Company to an increased H2 weighting or, depending upon the duration of the situation, potentially in to the Group's next financial year, which would lead to a reduction in our previous estimates for the current year's performance.

 

G&H remains financially secure and well placed to re-establish profitable growth when normal conditions return.

 

 

Further updates will be provided as and when appropriate.

 

 

 

For further information contact: -

 

Mark Webster/Chris Jewell

Gooch & Housego PLC

01460 256440

Mark Court /Charlotte Slater

Buchanan

020 7466 5000

Chris Baird/ Patrick Robb/

David Anderson

Investec Bank plc

020 7597 5970

 

 

 

 

 

 

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDJJMLTMTATBRM
Date   Source Headline
9th Mar 20097:00 amRNSMarket Update
29th Jan 20094:04 pmRNSTrading Update
1st Dec 200810:56 amRNSDirector Share Dealing
25th Nov 200812:27 pmRNSPreliminary Results - Replacement
25th Nov 20087:00 amRNSPreliminary Results
5th Nov 20087:00 amRNSNotice of Results
10th Oct 20087:00 amRNSAcquisition of General Optics
9th Oct 20087:00 amRNSFull Year Trading Update
25th Sep 200811:47 amRNSInvestor and Analyst Site Visits
19th Sep 20083:11 pmRNSShare Option Purchase
4th Jul 20087:00 amRNSAcquisition of General Optics
24th Jun 20087:00 amRNSChange of NOMAD & Broker
17th Jun 20087:00 amRNSInterim Results
27th May 20087:00 amRNSIFRS
13th May 20086:00 amRNSNotice of Results
9th Apr 20087:00 amRNSTrading Update
28th Mar 20089:59 amRNSAnnual Report and Accounts
12th Mar 20084:37 pmRNSAdditional Listing
13th Feb 200811:00 amRNSAGM Statement
5th Feb 20087:01 amRNSVendor Appreciation Award
22nd Jan 20087:01 amRNSGlobal Integration
7th Jan 20088:53 amRNSAdditional Listing
7th Jan 20087:01 amRNSSIFAM Order
4th Jan 200812:32 pmRNSDirector Shareholding
21st Dec 20074:46 pmRNSHolding(s) in Company
21st Dec 20074:35 pmRNSAdditional Listing
7th Dec 20073:00 pmRNSLong Term Incentive Plan
3rd Dec 200712:20 pmRNSAdditional Listing
30th Nov 20073:44 pmRNSHolding(s) in Company
27th Nov 20077:00 amRNSAppointment
27th Nov 20077:00 amRNSPreliminary Results
15th Nov 20077:01 amRNSAppointment
29th Oct 20077:01 amRNSNotice of Results
4th Oct 20077:01 amRNSFull Year Trading Update
23rd Aug 20078:26 amRNSAdditional Listing
22nd Aug 20075:38 pmRNSDirector Shareholdings
17th Aug 20076:23 pmRNSAIM Rule 26
16th Aug 20072:12 pmRNSAdditional Listing
14th Aug 200712:36 pmRNSLTIP Awards
10th Aug 20075:18 pmRNSDirector Shareholdings
17th Jul 20074:16 pmRNSDirector of Sales Appointment
5th Jun 20077:02 amRNSInterim Results
31st May 20079:55 amRNSTotal Voting Rights
10th May 20079:58 amRNSHolding(s) in Company
9th May 20077:01 amRNSNotice of Results
8th May 20071:53 pmRNSAdditional Listing
8th May 20077:02 amRNSAcquisition
11th Apr 20077:01 amRNSTrading Update
8th Mar 20075:54 pmRNSHolding(s) in Company
14th Feb 20077:01 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.